Plaque psoriasis — RACGP Fellowship MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Initiate topical corticosteroid combined with a vitamin D analogue and review response
Mild plaque psoriasis (4% BSA, no systemic features) should be managed with topical therapy, not systemic agents. Combination topical corticosteroid and vitamin D analogue improves efficacy and reduces adverse effects, consistent with Australian and international recommendations. Methotrexate is reserved for moderate‑to‑severe disease or when topical treatments fail. Oral prednisolone is contraindicated due to risk of rebound pustular psoriasis. Topical antibiotics are irrelevant, and doing nothing is inadequate.
Reference: PBS severity definitions and psoriasis treatment thresholds; PubMed: Diagnosis and management of psoriasis, 2017.